SAN DIEGO, CA - April 8, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC:QTZM), a pioneering biotechnology company specializing in computational enzyme engineering, is pleased to introduce Manu Bharath Khareedhi as an Independent Member of its Board of Directors. With extensive experience in biotechnology, business strategy, and global market expansion, Khareedhi’s leadership will be instrumental in accelerating Quantumzyme’s growth and enhancing its impact in the biocatalysis industry.
Manu Bharath Khareedhi is a seasoned executive with a proven track record in life sciences, biopharmaceuticals, and sustainable manufacturing. Throughout his career, he has been at the forefront of business transformation, strategic partnerships, and operational excellence. With deep expertise in biotechnology commercialization, he has played a key role in scaling innovative technologies into globally competitive solutions.
Khareedhi has successfully led multiple biotech enterprises, guiding them through product development, regulatory landscapes, and market expansion. His ability to identify growth opportunities, drive business efficiency, and foster strategic collaborations makes him a valuable addition to Quantumzyme’s Board.
As Independent Director, Manu Bharath Khareedhi will play a pivotal role in guiding Quantumzyme’s long-term strategy, focusing on:
- Expanding global partnerships to drive the adoption of sustainable enzymatic solutions.
- Enhancing commercialization strategies to bring Quantumzyme’s cutting-edge enzyme technologies to market.
- Strengthening corporate governance and operational excellence to scale up the company’s innovations.
- Supporting R&D advancements in AI-driven enzyme engineering for pharmaceuticals, chemicals, and renewable energy.
- Accelerating Quantumzyme’s growth trajectory by aligning business strategy with industry trends and emerging opportunities.
“I am excited to join Quantumzyme as an Independent Director at such a transformative time in the industry,” stated Manu Bharath Khareedhi. “Quantumzyme is at the forefront of next-generation enzyme engineering, redefining how industries approach sustainable manufacturing. I look forward to working with the leadership team to drive innovation, expand market opportunities, and create lasting impact in the biotechnology space.”
For the most current information and updates, please visit our website at www.quantumzymecorp.com.
About Quantumzyme Corp.
Quantumzyme Corp. is a pioneering biotransformation company revolutionizing chemical processes through sustainable, enzyme-based solutions. Specializing in green chemistry, it harnesses quantum mechanics, molecular modeling, AI-driven simulations, and computational enzyme engineering to design high-performance biocatalysts that enhance efficiency, reduce waste, and minimize environmental impact. By integrating computational modeling with wet-lab validation, Quantumzyme delivers scalable, cost-effective biocatalysis solutions that improve industrial sustainability. Offering end-to-end enzyme development services—from discovery and engineering to process optimization and scale-up—Quantumzyme empowers its partners to adopt greener, more efficient production methods. Committed to sustainability and innovation, the company envisions a future where biotechnology drives global solutions for climate change, pollution, and resource efficiency, making eco-friendly biocatalysis the industry standard.
Disclaimer
The information contained in this press release is provided by Quantumzyme Corp. (“Quantumzyme”) for general informational purposes only. This release may include forward-looking statements that reflect Quantumzyme’s current expectations, estimates, projections, and assumptions about future events, business performance, market conditions, or technological developments. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied in such statements. Forward-looking statements are based on management’s beliefs and assumptions as of the date of this press release and are subject to change without notice.
Quantumzyme makes no representations or warranties, express or implied, regarding the accuracy, completeness, or reliability of the information contained herein. The company undertakes no obligation to publicly update or revise any forward-looking statements as a result of new information, future developments, or changes in expectations, except as required by applicable law. Past performance should not be taken as an indicator of future results, and readers should not place undue reliance on any projections or expectations presented in this release.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor does it provide financial, investment, or legal advice. Any references to market trends, scientific advancements, or industry insights are provided for contextual purposes only and should not be interpreted as endorsements, guarantees, or definitive predictions of future developments. Readers and investors are encouraged to conduct their own due diligence and seek independent professional advice before making any investment or business decisions related to Quantumzyme or its affiliates.
Media Contact:
Naveen Kulkarni
Chief Executive Officer
Quantumzyme Corp.
15656 Bernardo Center Drive, Suite 801
San Diego, CA 92127
Phone: +1 (858) 203-0312
Email: info@quantumzymecorp.com
Website: www.quantumzymecorp.com
View the original release on www.newmediawire.com
